ELOCTATE
Google image searchProduct monograph
Active ingredient
antihemophilic factor (recombinant bdd), fc fusion protein, 3000 UNIT/VIAL
DIN: 02430355
Dosage form(s): KIT, POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE-USE VIAL (POWDER), PRE-FILLED SYRINGE (DILUENT)
Schedule: Schedule D
Company: SANOFI-AVENTIS CANADA INC
Date: 13-JAN-2022
ATC:
- B02 — ANTIHEMORRHAGICS (ATC, ATC/DDD, )
- B02B — VITAMIN K AND OTHER HEMOSTATICS (ATC, ATC/DDD)
- B02BD — Blood coagulation factors (ATC, ATC/DDD)
- B02BD02 — COAGULATION FACTOR VIII (ATC/DDD)
Reference brand drug: Adynovate, Eloctate, Esperoct, Jivi, Kovaltry, Nuwiq, Obizur, Xyntha, Zonovate
External Links for Eloctate
Search on Google
- Eloctate side effects
- Eloctate dosage
- antihemophilic factor side effects
- antihemophilic factor dosage
Sanofi-Aventis Canada Inc
Go to Sanofi-Aventis website to see drug product details. Sometimes you can find eloctate photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.